Agios Pharmaceuticals, Inc. (AGIO) SEC Filings — 2025
11 SEC filings for Agios Pharmaceuticals, Inc. (AGIO) in 2025.
Filings
- Agios Swings to Loss Amid R&D Surge, Lacking Prior Year's Windfalls — 10-Q · Oct 30, 2025
- Agios Pharmaceuticals Files 8-K — 8-K · Aug 4, 2025
- Agios Sees PYRUKYND Drive Q2 Revenue Growth — 10-Q · Jul 31, 2025
- Agios Pharmaceuticals Announces Board and Compensation Changes — 8-K · Jul 8, 2025
- Agios Pharmaceuticals Files 8-K: Officer Changes & Shareholder Votes — 8-K · Jun 18, 2025
- Agios Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 1, 2025
- Agios Pharmaceuticals DEF 14A Filing Details Executive Compensation — DEF 14A · Apr 25, 2025
- Agios Pharmaceuticals Announces Board and Compensation Changes — 8-K · Feb 13, 2025
- Agios Pharmaceuticals Files 2024 10-K — 10-K · Feb 13, 2025
- Agios Pharmaceuticals Files 8-K Report — 8-K · Jan 13, 2025
- Agios Pharmaceuticals Files 8-K Report — 8-K · Jan 6, 2025